FDA Approves Everolimus for Renal Angiomyolipomas Medscape April 26, 2012 — The US Food and Drug Administration has approved everolimus (Afinitor) for the treatment of renal angiomyolipomas not requiring immediate surgery, in patients with tuberous sclerosis complex. This marks the first drug ever to receive ... Novartis drug Afinitor® approved by FDA as first medication to treat patients ... FDA approves Novartis' Afinitor for treatment of renal angiomyolipomas and TSC FDA Approves Novartis's Afinitor Tablets To Treat Patients With Kidney Tumors |
